SNCA and synucleinopathy: To determine if results in the Drosophila α-synucleinopathy model extended to human cells, we used neurons differentiated from patient-derived induced pluripotent stem cells (iPSC) with a triplication of the α-synuclein locus and isogenic control cells (Devine et al., 2011; Ho et al., 2021).